Scancell Holdings PLC is a UK-based biotechnology company focused on developing innovative immunotherapies and cancer vaccines designed to stimulate the body's immune system to combat cancer. The company has built a diversified research platform spanning therapeutic cancer vaccines, antibody technologies and next-generation immunotherapy candidates. …
Solvonis Therapeutics PLC is a healthcare company focused on developing innovative therapies aimed at addressing unmet medical needs. Operating within the biotechnology and pharmaceutical research space, the company is building a pipeline of potential treatments through scientific innovation, clinical research, and strategic collaborations. Like …
Shield Therapeutics PLC is a specialty pharmaceutical company focused on the commercialization of innovative treatments for iron deficiency. The company has built its strategy around expanding the reach of its flagship oral iron therapy while increasing physician awareness, improving patient access, and entering new …
Growing commercial progress, expanding product visibility and the increasing global focus on microbiome-based healthcare have strengthened investor interest. As consumers and healthcare providers continue to seek scientifically backed skin health solutions, SkinBioTherapeutics is positioning itself in a niche segment with long-term growth potential.
THERACRYF PLC operates within the healthcare sector, focusing on advancing innovative therapies designed to address unmet medical needs. Companies operating in this space often attract investor attention due to the potential for breakthrough technologies, expanding commercial opportunities and strategic partnerships. As healthcare innovation continues …
Image Scan Holdings (LSE:IGE) featured among the UK's biggest daily gainers, rising about 2.4% on a relative-volume reading many times its normal level. Image Scan makes X-ray screening and detection systems.
Hikma Pharmaceuticals Plc came under selling pressure after investors reduced exposure to several large-cap healthcare stocks during the trading session.
Ondine Biomedical remains firmly on investors' watchlists following continued progress across its clinical development programme and growing commercial adoption of its proprietarySteriwaveinfection prevention technology.
• The decline largely reflectedprofit booking after an exceptional rallywitnessed over recent months rather than any major negative company-specific announcement.
Smith & Nephew plc (LSE:SN.), one of the world's largest medical technology companies, attracted investor attention after its shares traded lower during today's session.